Diferencia entre revisiones de «Template:Heavy metals list»

Sin resumen de edición
Línea 1: Línea 1:
===[[Heavy metal]] toxicity===
==Background==
Heavy metal toxicity results from exposure to metals like lead, mercury, arsenic, or cadmium, which interfere with cellular function. Exposure may occur occupationally, environmentally, through ingestion, or from alternative medicines. Chronic toxicity can present insidiously, while acute toxicity may mimic sepsis or encephalopathy. Diagnosis is often delayed due to nonspecific symptoms.
 
==Clinical Features==
Symptoms depend on the metal and exposure duration but may include:
 
Neurologic: Peripheral neuropathy, confusion, tremor, encephalopathy
 
GI: Abdominal pain, nausea, vomiting, diarrhea, anorexia
 
Heme: Anemia (especially microcytic or hemolytic), basophilic stippling (lead)
 
Renal: Tubular dysfunction, proteinuria, Fanconi syndrome
 
Dermatologic: Mees’ lines (arsenic), hyperpigmentation, hair loss
 
Others: Fatigue, weight loss, hypertension (cadmium), immunosuppression
 
==Differential Diagnosis==
 
Sepsis or systemic inflammatory response
 
Drug toxicity or overdose
 
Metabolic disorders (e.g., porphyria, uremia)
 
Psychiatric illness (if symptoms are vague or bizarre)
 
Neurologic diseases (e.g., Guillain-Barré, MS, Parkinson’s)
 
Vitamin deficiencies (e.g., B12, thiamine)
 
==Evaluation==
 
===Workup===
 
History: Occupational exposures, home remedies, hobbies (e.g., jewelry making, battery recycling), diet, water source, imported goods
 
Labs:
 
CBC, CMP, urinalysis
 
Blood lead level, serum/urine arsenic, mercury, or cadmium (based on suspicion)
 
Urine heavy metal screen (note: spot testing may require creatinine correction)
 
Imaging: Abdominal X-ray (radiopaque material in GI tract, especially with lead)
 
EKG: Evaluate for QT prolongation or arrhythmias in severe cases
 
===Diagnosis===
Confirmed by elevated blood or urine levels of the specific metal in the context of clinical findings. Hair and nail testing are unreliable for acute toxicity. Interpret results with toxicologist input if possible.
 
==Management==
 
Remove the source of exposure (e.g., occupational control, GI decontamination if recent ingestion)
 
Supportive care: IV fluids, seizure control, electrolyte repletion
 
Chelation therapy (in consultation with toxicology or Poison Control):
 
Lead: EDTA, dimercaprol (BAL), succimer
 
Mercury/arsenic: Dimercaprol or DMSA
 
Cadmium: No effective chelation—focus on supportive care
 
Notify local public health authorities if exposure source is environmental or occupational
 
==Disposition==
 
Admit if symptomatic, unstable, or requiring chelation
 
Discharge may be appropriate for asymptomatic patients with low-level exposure and outpatient follow-up
 
Arrange toxicology or environmental medicine follow-up for source control and serial testing
 
==See Also==
*[[Aluminum toxicity]]
*[[Aluminum toxicity]]
*[[Antimony toxicity]]
*[[Antimony toxicity]]

Revisión del 22:28 7 jun 2025

Background

Heavy metal toxicity results from exposure to metals like lead, mercury, arsenic, or cadmium, which interfere with cellular function. Exposure may occur occupationally, environmentally, through ingestion, or from alternative medicines. Chronic toxicity can present insidiously, while acute toxicity may mimic sepsis or encephalopathy. Diagnosis is often delayed due to nonspecific symptoms.

Clinical Features

Symptoms depend on the metal and exposure duration but may include:

Neurologic: Peripheral neuropathy, confusion, tremor, encephalopathy

GI: Abdominal pain, nausea, vomiting, diarrhea, anorexia

Heme: Anemia (especially microcytic or hemolytic), basophilic stippling (lead)

Renal: Tubular dysfunction, proteinuria, Fanconi syndrome

Dermatologic: Mees’ lines (arsenic), hyperpigmentation, hair loss

Others: Fatigue, weight loss, hypertension (cadmium), immunosuppression

Differential Diagnosis

Sepsis or systemic inflammatory response

Drug toxicity or overdose

Metabolic disorders (e.g., porphyria, uremia)

Psychiatric illness (if symptoms are vague or bizarre)

Neurologic diseases (e.g., Guillain-Barré, MS, Parkinson’s)

Vitamin deficiencies (e.g., B12, thiamine)

Evaluation

Workup

History: Occupational exposures, home remedies, hobbies (e.g., jewelry making, battery recycling), diet, water source, imported goods

Labs:

CBC, CMP, urinalysis

Blood lead level, serum/urine arsenic, mercury, or cadmium (based on suspicion)

Urine heavy metal screen (note: spot testing may require creatinine correction)

Imaging: Abdominal X-ray (radiopaque material in GI tract, especially with lead)

EKG: Evaluate for QT prolongation or arrhythmias in severe cases

Diagnosis

Confirmed by elevated blood or urine levels of the specific metal in the context of clinical findings. Hair and nail testing are unreliable for acute toxicity. Interpret results with toxicologist input if possible.

Management

Remove the source of exposure (e.g., occupational control, GI decontamination if recent ingestion)

Supportive care: IV fluids, seizure control, electrolyte repletion

Chelation therapy (in consultation with toxicology or Poison Control):

Lead: EDTA, dimercaprol (BAL), succimer

Mercury/arsenic: Dimercaprol or DMSA

Cadmium: No effective chelation—focus on supportive care

Notify local public health authorities if exposure source is environmental or occupational

Disposition

Admit if symptomatic, unstable, or requiring chelation

Discharge may be appropriate for asymptomatic patients with low-level exposure and outpatient follow-up

Arrange toxicology or environmental medicine follow-up for source control and serial testing

See Also